查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
双特异性抗体治疗合约製造市场，按适应症、给药途径、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1419079

双特异性抗体治疗合约製造市场，按适应症、给药途径、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Bispecific Antibody Therapeutics Contract Manufacturing Market, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年双特异性抗体治疗合约製造市场规模为52.891亿美元，2023年至2030年CAGR为36.23%。

双特异性抗体治疗合约製造市场-市场动态

越来越重视新疗法的开发和研发投资以推动市场需求

在预测期内，双特异性抗体（bsAB）疗法的合约製造市场预计将成长，这主要是由于旨在寻找新疗法的研发工作的增加。在过去几年中，市场呈指数级扩张，预计这种趋势将在分析期间持续下去。造成这种情况的主要原因是在整个预测期间可能会引入双特异性抗体的强大管道。此外，市场获利扩张的关键驱动因素是抗癌治疗产品线的不断扩大。例如，根据美国 FDA 的数据，截至 2022 年，临床试验中超过 85% 的双特异性抗体旨在治疗癌症。

此外，由于双特异性抗体疗法在治疗癌症和其他疾病方面具有如此巨大的治疗潜力，因此自大流行以来，对它们的需求一直在增加。此外，几种双特异性抗体目前正处于临床开发的早期阶段。因此，在未来几年，预计这方面将对市场成长产生正面影响。此外，双特异性抗体疗法正在开发中，预计将增加市场扩张机会。

双特异性抗体治疗合约製造市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 36.23% 左右的CAGR成长
  • 根据适应症细分，由于对癌症免疫治疗的高需求，预计癌症细分市场将在 2022 年显示最大的市场份额。
  • 根据给药途径细分，静脉注射部分是 2022 年的领先部分，主要是由于其在癌症和免疫系统建构方面的有效性。
  • 根据最终用户细分，生物製药公司细分市场是 2022 年的领先细分市场，这主要是由于临床试验需求的增加。
  • 从地区来看，由于高研发和新药发现，北美是 2022 年的主要收入来源。

双特异性抗体治疗合约製造市场-細項分析：

全球双特异性抗体治疗合约製造市场根据适应症、给药途径、最终用户和地区进行细分。

根据适应症，市场分为五类：癌症、传染病、自体发炎和自体免疫疾病、中枢神经系统疾病等。癌症领域占市场主导地位。癌症有效疗法的快速发展正在推动细分市场的成长。

根据给药途径，市场分为三类：静脉注射、皮下注射和其他。静脉注射细分市场在市场上占据主导地位，并可能在预测期内保持其主导地位。皮下给药途径的日益采用可能会促进市场成长。

根据最终用户，市场分为三类：生物製药公司、研究机构和其他。生物製药公司细分市场占据主导地位，并可能在预测期内保持其主导地位。对新药和改进药物的需求增加正在推动治疗需求。

双特异性抗体治疗合约製造市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

双特异性抗体治疗合约製造市场-竞争格局：

双特异性抗体治疗合约製造市场本质上竞争适度。市场上的主要参与者都致力于采用无机策略倡议，例如併购、合作伙伴关係和研发活动。例如，欧盟委员会于2022年6月授权有条件上市CD20xCD3 T细胞结合药物bsAB Lunsumio（mosunetuzumab），将适用于復发或抗药性滤泡性淋巴瘤患者。

最近的发展：

2023 年 3 月，InvoX Pharma Limited 报告称，InvoX 子公司 F-star 已同意与武田合作开发免疫肿瘤学 bsAB。

目录

第 1 章：双特异性抗体治疗合约製造市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 双特异性抗体治疗合约製造市场片段（按适应症）
    • 按给药途径分類的双特异性抗体治疗合约製造市场片段
    • 最终用户的双特异性抗体治疗合约製造市场片段
    • 按国家/地区分類的双特异性抗体治疗合约製造市场片段
    • 按地区分類的双特异性抗体治疗合约製造市场片段
  • 竞争洞察

第 3 章：双特异性抗体治疗合约製造主要市场趋势

  • 双特异性抗体治疗合约製造市场驱动因素
    • 市场驱动因素的影响分析
  • 双特异性抗体治疗合约製造市场限制
    • 市场限制影响分析
  • 双特异性抗体治疗合约製造市场机会
  • 双特异性抗体治疗合约製造市场未来趋势

第 4 章：双特异性抗体治疗合约製造业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：双特异性抗体治疗合约製造市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：双特异性抗体治疗合约製造市场格局

  • 2022 年双特异性抗体治疗合约製造市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：双特异性抗体治疗合约製造市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 癌症
    • 传染性疾病
    • 自体发炎与自体免疫疾病
    • 中枢神经系统疾病
    • 其他的

第 8 章：双特异性抗体治疗合约製造市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 静脉
    • 皮下
    • 其他的

第 9 章：双特异性抗体治疗合约製造市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生物製药公司
    • 研究机构
    • 其他的

第 10 章：双特异性抗体治疗合约製造市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 双特异性抗体疗法合约製造北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 双特异性抗体疗法合约製造欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 双特异性抗体疗法合约製造亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 双特异性抗体疗法合约製造拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 双特异性抗体疗法合约製造中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 双特异性抗体治疗合约製造业

  • 竞争仪表板
  • 公司简介
    • Lonza Group
    • Roche's
    • Thermo Fisher Scientific
    • Creative Biolabs
    • AbbVie
    • Amgen
    • Janssen
    • Johnson & Johnson
    • IQVIA
    • WuXi Biologics
    • Context Therapeutics
    • Sino Biological Inc.
    • KBI Biopharma
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2144

REPORT HIGHLIGHT

Bispecific Antibody Therapeutics Contract Manufacturing Market size was valued at USD 5,289.1 Million in 2022, expanding at a CAGR of 36.23% from 2023 to 2030.

Therapeutics using bispecific antibodies Contract manufacturing is the practice of contracting out to specialist contract manufacturing organizations (CMOs) the manufacturing procedures involved in creating bispecific antibodies. Bispecific antibodies are a class of medicinal compounds designed to target two different antigens at the same time. These antigens are frequently found on the surface of cells that are linked to diseases such as infectious diseases, autoimmune disorders, and cancer.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Market Dynamics

Increasing emphasis on novel therapeutics development and R&D investment to propel market demand

During the forecast period, the market for contract manufacturing of bispecific antibody (bsAB) therapies is expected to grow primarily due to increased research and development efforts aimed at finding new therapeutics. The market has been seeing exponential expansion over the last few years, and this trend is expected to continue over the analysis period. The main reason for this is the strong pipeline of bispecific antibodies that will probably be introduced throughout the projection period. Moreover, a key driver of the market's profitable expansion is the expanding pipeline of anti-cancer treatments. For example, according to the U.S. FDA, more than 85% of bispecific antibodies in clinical trials are intended to treat cancer as of 2022.

Furthermore, as bispecific antibody therapies have such significant therapeutic potential in treating cancer and other disorders, there has been an increase in demand for them since the pandemic. Moreover, several bispecific antibodies are now in the early stages of clinical development. Therefore, in the upcoming years, it is anticipated that this aspect will positively affect market growth. Furthermore, there is a developing pipeline of bispecific antibody therapies, which is anticipated to boost market expansion opportunities.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 36.23% over the forecast period (2023-2030)
  • Based on Indication segmentation, cancer segment was predicted to show maximum market share in the year 2022, owing to high need for cancer immunotherapy.
  • Based on Route of Administration segmentation, intravenous segment was the leading segment in 2022, mainly due to its effectiveness in cancer and immune system building.
  • Based on End-User segmentation, biopharmaceutical companies' segment was the leading segment in 2022, mainly due to increasing demand from clinical trials.
  • On the basis of region, North America was the leading revenue generator in 2022, owing to high R&D and novel drugs discovery.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Segmentation Analysis:

The Global Bispecific Antibody Therapeutics Contract Manufacturing Market is segmented on the basis of Indication, Route of Administration, End-User, and Region.

The market is divided into five categories based on Indication: cancer, infectious diseases, autoinflammatory and autoimmune diseases, CNS Conditions, and others. The cancer segment dominates the market. Rapid developments in cancer effective therapies are boosting segment growth.

The market is divided into three categories based on Route of Administration: intravenous, subcutaneous, and others. The intravenous segment dominates the market and is likely to maintain its dominance during the forecast period. The growing adoption of the subcutaneous route of administration is likely to boost market growth.

The market is divided into three categories based on End-User: biopharmaceutical companies, research institutes, and others. The biopharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. Increased need for new and improved drugs is boosting the therapeutics demand.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bispecific Antibody Therapeutics Contract Manufacturing Market- Competitive Landscape:

Bispecific antibody therapeutics contract manufacturing market is moderately competitive in nature. The major players in the market are engaged on the adoption of in-organic strategic initiatives, such as mergers & acquisitions, partnerships, and R&D activities. For example, the European Commission authorized the conditional marketing of bsAB Lunsumio (mosunetuzumab), a CD20xCD3 T-cell binding drug, in June 2022. It will be applied to patients with relapsed or resistant follicular lymphoma.

Recent Developments:

In March 2023, InvoX Pharma Limited reported that F-star, a subsidiary of InvoX, has agreed to collaborate with Takeda on an immuno-oncology bsAB.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Roche's
  • Thermo Fisher Scientific
  • Creative Biolabs
  • AbbVie
  • Amgen
  • Janssen
  • Johnson & Johnson
  • IQVIA
  • WuXi Biologics
  • Context Therapeutics
  • Sino Biological Inc.
  • KBI Biopharma
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY INDICATION

  • Cancer
  • Infectious diseases
  • Autoinflammatory and autoimmune diseases
  • CNS Conditions
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenous
  • Subcutaneous
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY END-USER

  • Biopharmaceutical companies
  • Research institutes
  • Others

GLOBAL BISPECIFIC ANTIBODY THERAPEUTICS CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Bispecific Antibody Therapeutics Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Indication
    • 2.1.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Route of Administration
    • 2.1.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by End-User
    • 2.1.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Country
    • 2.1.5. Bispecific Antibody Therapeutics Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Bispecific Antibody Therapeutics Contract Manufacturing Key Market Trends

  • 3.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bispecific Antibody Therapeutics Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bispecific Antibody Therapeutics Contract Manufacturing Market Opportunities
  • 3.4. Bispecific Antibody Therapeutics Contract Manufacturing Market Future Trends

4. Bispecific Antibody Therapeutics Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bispecific Antibody Therapeutics Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Bispecific Antibody Therapeutics Contract Manufacturing Market Landscape

  • 6.1. Bispecific Antibody Therapeutics Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Cancer
    • 7.1.3. Infectious diseases
    • 7.1.4. Autoinflammatory and autoimmune diseases
    • 7.1.5. CNS Conditions
    • 7.1.6. Others

8. Bispecific Antibody Therapeutics Contract Manufacturing Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Intravenous
    • 8.1.3. Subcutaneous
    • 8.1.4. Others

9. Bispecific Antibody Therapeutics Contract Manufacturing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Biopharmaceutical companies
    • 9.1.3. Research institutes
    • 9.1.4. Others

10. Bispecific Antibody Therapeutics Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Bispecific Antibody Therapeutics Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Bispecific Antibody Therapeutics Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Lonza Group
    • 11.2.2. Roche's
    • 11.2.3. Thermo Fisher Scientific
    • 11.2.4. Creative Biolabs
    • 11.2.5. AbbVie
    • 11.2.6. Amgen
    • 11.2.7. Janssen
    • 11.2.8. Johnson & Johnson
    • 11.2.9. IQVIA
    • 11.2.10. WuXi Biologics
    • 11.2.11. Context Therapeutics
    • 11.2.12. Sino Biological Inc.
    • 11.2.13. KBI Biopharma
    • 11.2.14. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User 2018-2030 (USD Million)
  • TABLE Bispecific Antibody Therapeutics Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bispecific Antibody Therapeutics Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Bispecific Antibody Therapeutics Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Germany Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE India Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Brazil Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Bispecific Antibody Therapeutics Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Bispecific Antibody Therapeutics Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)